Home > Journals > Italian Journal of Vascular and Endovascular Surgery > Past Issues > Giornale Italiano di Chirurgia Vascolare 2003 March;10(1) > Giornale Italiano di Chirurgia Vascolare 2003 March;10(1):15-25

CURRENT ISSUEITALIAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

A Journal on Vascular and Endovascular Surgery


Official Journal of the Italian Society of Vascular and Endovascular Surgery
Indexed/Abstracted in: EMBASE, Scopus

 

ORIGINAL ARTICLES  


Giornale Italiano di Chirurgia Vascolare 2003 March;10(1):15-25

language: English, Italian

Endovascular treatment of critical limb ischemia in diabetic patients

Porcellini M., Del Guercio L., Cecere D., Spinetti F., Di Lella D., Bracale G.

Cattedra di Chirurgia Vascolare Università degli Studi di Napoli Federico II, Napoli


PDF  REPRINTS


Background. The influ­ence of dia­betes on ­limb sal­vage is a con­tro­ver­sial ques­tion. The aim of ­this ­study was to eval­u­ate the out­comes of dia­bet­ic ­patients and non-dia­bet­ic ­patients ­with crit­i­cal ­limb ische­mia under­go­ing arte­ri­al endo­vas­cu­lar pro­ce­dures.
Methods. The ­records of 33 con­sec­u­tive ­patients who had under­gone endo­vas­cu­lar treat­ment for ­limb-threat­en­ing ische­mia ­over the ­past 7 ­years, includ­ing dia­bet­ic ­patients (Group I; n=16) and non-dia­bet­ic ­patients (Group II; n=17), ­were ­reviewed.
Results. No sig­nif­i­cant dif­fer­enc­es ­were ­found ­between Group I and II ­patients ­with ­respect to age, gen­der, ­risk fac­tors, sur­gi­cal indi­ca­tions, pre­op­er­a­tive ­ankle-bra­chi­al indi­ces. The ­limb sal­vage ­rates for Group I and II ­patients 30 ­days ­after treat­ment ­were 77.8% and 94.4% (p = n.s.), respec­tive­ly. Of 4 ear­ly ampu­ta­tions in the dia­bet­ic ­group, 3 ­were per­formed in ­limbs ­with pat­ent revas­cu­lar­isa­tion. There was no pro­ce­dure-relat­ed ­death (<30 ­days). After a ­median fol­low-up of 25 ­months (­range 9-84 ­months) in dia­bet­ic ­patients and 30 ­months (­range 7-72 ­months) in non-dia­bet­ic ­patients, the ­limb sur­vi­val ­rates ­were 66.7% and 83.3% (p = not sig­nif­i­cant). Three (18.7%) ­late ­deaths ­occurred in Group I and 1 (5.9%) in Group II ­patients (p = not sig­nif­i­cant) ­from car­diac dis­ease or can­cer.
Conclusions. The ­results of arte­ri­al endo­vas­cu­lar ther­a­py in dia­bet­ic ­patients ­showed ­limb-sal­vage ­rates sim­i­lar to ­those ­found in non-dia­bet­ic ­patients.

top of page